Praluent (Alirocumab) in East Asian Patients: Documented Efficacy Gaps and Dosing Considerations
A clinical deep-dive into alirocumab efficacy differences in East Asian populations, covering pharmacogenomics, ethnicity-stratified trial data, PCSK9 biology, and dosing guidance for this group.
Read clinical review